Expertise in
33
conditions

Dr. Orin Bloch

Neurosurgery
Office
4860 Y St Ste 3740, 
Sacramento, CA 
Offers Telehealth
Expertise in
33
conditions
Office
4860 Y St Ste 3740, 
Sacramento, CA 

Overview

Orin Bloch is a Neurosurgery provider practicing medicine in Sacramento, California.

Dr. Bloch is highly rated in 33 conditions, according to our data. His clinical expertise encompasses Glioblastoma, Astrocytoma, Meningioma, Awake Craniotomy, and Gamma Knife Radiosurgery.

He is actively involved in clinical research, co-authoring 99 peer reviewed articles and participating in 4 clinical trials.

Specialties

Neurosurgery

Licenses

Neurological Surgery in IL

Hospital Affiliations

Marshall Medical Center
University Of California Davis Medical Center
Enloe Health
Adventist Health And Rideout

Languages Spoken

English

Gender

Male

Insurance

Accepted insurance can change. Please verify directly with the provider.

Find your insurance
Find your insuranceClose

Accepted insurance plans:

Alignment Health Plan
  • MEDICARE MAPD
  • MEDICARE SNP
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
Anthem BCBS
  • EPO
  • HMO
  • POS
  • PPO
Blue Shield of California
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE-MEDICAID PLAN
  • OTHER COMMERCIAL
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
  • PPO
Cigna
  • EPO
  • HMO
  • PPO
Humana
  • HMO
  • INDEMNITY
  • POS
  • PPO
Medicaid
  • OTHER MEDICAID
  • STATE MEDICAID
UnitedHealthcare
  • EPO
  • HMO
  • POS
  • PPO
Wellcare
  • EPO
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
View 3 Less Insurance Carriers -

Locations

Office
4860 Y St Ste 3740, Sacramento, CA 95817
Other Locations
Office
3160 Folsom Blvd Ste 3900, Sacramento, CA 95816

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

4 Clinical Trials

A Phase II Study of Checkpoint Blockade Immunotherapy in Patients With Somatically Hypermutated Recurrent WHO Grade 4 Glioma
A Phase II Study of Checkpoint Blockade Immunotherapy in Patients With Somatically Hypermutated Recurrent WHO Grade 4 Glioma
Enrollment Status: Active_not_recruiting
Publish Date: August 31, 2026
Intervention Type: Procedure, Biological
Study Drugs: Ipilimumab, Nivolumab
Study Phase: Phase 2
A Phase II Randomized Trial Comparing the Efficacy of Heat Shock Protein-Peptide Complex-96 (HSPPC-96) (NSC #725085, ALLIANCE IND # 15380) Vaccine Given With Bevacizumab Versus Bevacizumab Alone in the Treatment of Surgically Resectable Recurrent Glioblastoma Multiforme (GBM)
A Phase II Randomized Trial Comparing the Efficacy of Heat Shock Protein-Peptide Complex-96 (HSPPC-96) (NSC #725085, ALLIANCE IND # 15380) Vaccine Given With Bevacizumab Versus Bevacizumab Alone in the Treatment of Surgically Resectable Recurrent Glioblastoma Multiforme (GBM)
Enrollment Status: Terminated
Publish Date: January 24, 2025
Intervention Type: Biological, Drug
Study Drugs: HSPPC-96, Bevacizumab
Study Phase: Phase 2
A Phase 0 First-In-Human Study Using NU-0129: A Spherical Nucleic Acid (SNA) Gold Nanoparticle Targeting BCL2L12 in Recurrent Glioblastoma Multiforme or Gliosarcoma Patients
A Phase 0 First-In-Human Study Using NU-0129: A Spherical Nucleic Acid (SNA) Gold Nanoparticle Targeting BCL2L12 in Recurrent Glioblastoma Multiforme or Gliosarcoma Patients
Enrollment Status: Completed
Publish Date: August 26, 2022
Intervention Type: Other, Drug
Study Phase: Early Phase 1
A Phase II, Open Label, Clinical Trial Of Pre-Surgical and Adjuvant Treatment of Recurrent Malignant Glioma With Tremelimumab and Durvalumab (MEDI4736) Alone and in Combination to Determine Immunologic Changes From Treatment
A Phase II, Open Label, Clinical Trial Of Pre-Surgical and Adjuvant Treatment of Recurrent Malignant Glioma With Tremelimumab and Durvalumab (MEDI4736) Alone and in Combination to Determine Immunologic Changes From Treatment
Enrollment Status: Completed
Publish Date: April 18, 2022
Intervention Type: Biological, Procedure, Other
Study Drugs: Durvalumab, Tremelimumab
Study Phase: Phase 2
View 3 Less Clinical Trials

99 Total Publications

Metabolomic and lipidomic profiling reveals distinct subtypes of glioblastoma IDH-wildtype and shared metabolic features with astrocytoma IDH-mutant grade 4.
Metabolomic and lipidomic profiling reveals distinct subtypes of glioblastoma IDH-wildtype and shared metabolic features with astrocytoma IDH-mutant grade 4.
Journal: Neuro-oncology advances
Published: June 17, 2026
Similar Doctors
Expertise in
16
conditions
Dr. Rudolph J. Schrot
Neurosurgery | Neurology
Expertise in
16
conditions
Dr. Rudolph J. Schrot
Neurosurgery | Neurology
Referral required
Before you request

Sutter NeuroScience Medical Group

2800 L St, Ste 501, 
Sacramento, CA 
 (1.6 miles away)
916-454-6850
Languages Spoken:
English
See accepted insurances
Accepting New Patients
Offers Telehealth

Rudolph Schrot is a Neurosurgery specialist and a Neurologist practicing medicine in Sacramento, California. Dr. Schrot is highly rated in 16 conditions, according to our data. His clinical expertise encompasses Tarlov Cysts, Cervical Spondylosis, Notalgia Paresthetica, Sacral Nerve Stimulation, and Laminectomy. Dr. Schrot is board certified in Neurosurgery - Board Certified and Neurological Surgery. Dr. Schrot is currently accepting new patients.

Expertise in
37
conditions
Expertise in
37
conditions
Referral may be required

Regents Of The Univ. Of CA

4860 Y St, 
Sacramento, CA 
 (0.4 miles away)
916-734-4300
Languages Spoken:
English
See accepted insurances
Offers Telehealth

Kiarash Shahlaie is a Neurosurgery provider practicing medicine in Sacramento, California. Dr. Shahlaie is highly rated in 37 conditions, according to our data. His clinical expertise encompasses Meningioma, Pituitary Tumor, Seizures, Deep Brain Stimulation, and Osteotomy.

Expertise in
65
conditions
Dr. Cormac O. Maher
Neurosurgery
Expertise in
65
conditions
Dr. Cormac O. Maher
Neurosurgery
Referral may be required

Stanford Medicine Children's Health Specialty Services-Walnut Creek-Pediatric Neurolog

106 La Casa Via, 
Walnut Creek, CA 
 (54.4 miles away)
925-239-2900
Languages Spoken:
English
See accepted insurances
Offers Telehealth

Cormac Maher is a Neurosurgery provider practicing medicine in Walnut Creek, California. Dr. Maher is highly rated in 65 conditions, according to our data. His clinical expertise encompasses Arachnoid Cysts, Chiari Malformation, Chiari Malformation Type 2, Posterior Fossa Decompression, and Laminectomy.

Frequently Asked Questions about Dr. Orin Bloch

How do I make an appointment with Dr. Orin Bloch?

You can book an appointment with Dr. Orin Bloch by calling their office at 916-734-4300. MediFind provides direct contact information so you can schedule visits, second opinions, or consultations without navigating third-party calendars.

Is Dr. Orin Bloch a top-rated expert for Glioblastoma?

MediFind is an objective health platform that identifies experts based on real-world data. Dr. Orin Bloch is classified as an Elite expert for Glioblastoma, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

What conditions does Dr. Orin Bloch specialize in?

While Dr. Orin Bloch is a Neurosurgery, they have specific expertise in Glioblastoma, Astrocytoma, and Meningioma. MediFind analyzes a doctor's articles and referral patterns to identify their specific areas of focus within Neurosurgery.

Does Dr. Orin Bloch participate in research or clinical trials?

Yes. Dr. Orin Bloch has published 99 articles and abstracts on conditions like Glioblastoma. You can view a list of Dr. Orin Bloch's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.

Does Dr. Orin Bloch accept my insurance?

Dr. Orin Bloch accepts most major insurance plans, including Alignment Health Plan and Anthem BCBS. We recommend calling the office directly at 916-734-4300 to verify that your specific plan is currently accepted before your visit.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. Bloch's expertise for a condition
ConditionClose
View All 14 Distinguished Conditions
View All 15 Advanced Conditions
View All 43 Experienced Conditions
Want to save this doctor for later?
Sign Up
Is this your doctor?
Find A Second Opinion
Not sure about your diagnosis?
Check Your Symptoms
 
 
 
 
Learn about our expert tiers
Learn More
Are you the provider on this profile?
Claim Profile